nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—CYP3A4—chronic kidney failure	0.176	0.546	CbGaD
Bosutinib—ABCB1—chronic kidney failure	0.147	0.454	CbGaD
Bosutinib—Vandetanib—VEGFA—chronic kidney failure	0.00225	0.304	CrCbGaD
Bosutinib—Gefitinib—CYP2C19—chronic kidney failure	0.00103	0.14	CrCbGaD
Bosutinib—Gefitinib—CYP1A1—chronic kidney failure	0.00103	0.14	CrCbGaD
Bosutinib—Vandetanib—CYP3A4—chronic kidney failure	0.000692	0.0937	CrCbGaD
Bosutinib—Gefitinib—CYP3A4—chronic kidney failure	0.000657	0.0891	CrCbGaD
Bosutinib—STK24—blood—chronic kidney failure	0.000627	0.00234	CbGeAlD
Bosutinib—CLK1—cardiovascular system—chronic kidney failure	0.000626	0.00234	CbGeAlD
Bosutinib—BCR—cortex of kidney—chronic kidney failure	0.000626	0.00234	CbGeAlD
Bosutinib—NUAK2—cortex of kidney—chronic kidney failure	0.000626	0.00234	CbGeAlD
Bosutinib—MAP2K1—kidney—chronic kidney failure	0.000625	0.00233	CbGeAlD
Bosutinib—CLK1—urethra—chronic kidney failure	0.000623	0.00233	CbGeAlD
Bosutinib—HCK—urethra—chronic kidney failure	0.000623	0.00233	CbGeAlD
Bosutinib—MAP3K2—nephron tubule—chronic kidney failure	0.000622	0.00232	CbGeAlD
Bosutinib—CSK—kidney—chronic kidney failure	0.000621	0.00232	CbGeAlD
Bosutinib—STK36—gonad—chronic kidney failure	0.000619	0.00231	CbGeAlD
Bosutinib—CSNK1A1—kidney—chronic kidney failure	0.000617	0.0023	CbGeAlD
Bosutinib—LRRK2—renal system—chronic kidney failure	0.000617	0.0023	CbGeAlD
Bosutinib—CAMK2G—cardiovascular system—chronic kidney failure	0.000615	0.0023	CbGeAlD
Bosutinib—CLK1—kidney—chronic kidney failure	0.000613	0.00229	CbGeAlD
Bosutinib—CAMK2G—urethra—chronic kidney failure	0.000611	0.00228	CbGeAlD
Bosutinib—TBK1—nephron tubule—chronic kidney failure	0.000609	0.00227	CbGeAlD
Bosutinib—PTK2—nephron tubule—chronic kidney failure	0.000609	0.00227	CbGeAlD
Bosutinib—FER—blood—chronic kidney failure	0.000606	0.00226	CbGeAlD
Bosutinib—ALK—blood—chronic kidney failure	0.000606	0.00226	CbGeAlD
Bosutinib—LRRK2—urethra—chronic kidney failure	0.000606	0.00226	CbGeAlD
Bosutinib—CSK—cortex of kidney—chronic kidney failure	0.000605	0.00226	CbGeAlD
Bosutinib—Vandetanib—ALB—chronic kidney failure	0.000604	0.0818	CrCbGaD
Bosutinib—LYN—blood—chronic kidney failure	0.000603	0.00225	CbGeAlD
Bosutinib—PTK2B—renal system—chronic kidney failure	0.000601	0.00224	CbGeAlD
Bosutinib—CSNK1A1—cortex of kidney—chronic kidney failure	0.000601	0.00224	CbGeAlD
Bosutinib—MAP4K4—gonad—chronic kidney failure	0.0006	0.00224	CbGeAlD
Bosutinib—CLK1—cortex of kidney—chronic kidney failure	0.000597	0.00223	CbGeAlD
Bosutinib—IRAK1—nephron tubule—chronic kidney failure	0.000597	0.00223	CbGeAlD
Bosutinib—LRRK2—kidney—chronic kidney failure	0.000596	0.00223	CbGeAlD
Bosutinib—BCR—gonad—chronic kidney failure	0.000596	0.00223	CbGeAlD
Bosutinib—MAP4K1—blood—chronic kidney failure	0.000594	0.00222	CbGeAlD
Bosutinib—PTK2B—cardiovascular system—chronic kidney failure	0.000594	0.00222	CbGeAlD
Bosutinib—MAP3K12—gonad—chronic kidney failure	0.000592	0.00221	CbGeAlD
Bosutinib—BTK—blood—chronic kidney failure	0.000591	0.00221	CbGeAlD
Bosutinib—ROCK1—digestive system—chronic kidney failure	0.000587	0.00219	CbGeAlD
Bosutinib—CAMK2G—cortex of kidney—chronic kidney failure	0.000586	0.00219	CbGeAlD
Bosutinib—SIK1—renal system—chronic kidney failure	0.000582	0.00217	CbGeAlD
Bosutinib—PTK2B—kidney—chronic kidney failure	0.000581	0.00217	CbGeAlD
Bosutinib—CSNK1E—urethra—chronic kidney failure	0.000581	0.00217	CbGeAlD
Bosutinib—LRRK2—cortex of kidney—chronic kidney failure	0.000581	0.00217	CbGeAlD
Bosutinib—MAP2K1—gonad—chronic kidney failure	0.00058	0.00216	CbGeAlD
Bosutinib—STK35—gonad—chronic kidney failure	0.00058	0.00216	CbGeAlD
Bosutinib—CSK—gonad—chronic kidney failure	0.000576	0.00215	CbGeAlD
Bosutinib—MAP4K2—blood—chronic kidney failure	0.000574	0.00215	CbGeAlD
Bosutinib—Gefitinib—ALB—chronic kidney failure	0.000573	0.0777	CrCbGaD
Bosutinib—CSNK1A1—gonad—chronic kidney failure	0.000572	0.00214	CbGeAlD
Bosutinib—SIK1—urethra—chronic kidney failure	0.000572	0.00213	CbGeAlD
Bosutinib—IRAK4—urethra—chronic kidney failure	0.000572	0.00213	CbGeAlD
Bosutinib—ERBB3—renal system—chronic kidney failure	0.00057	0.00213	CbGeAlD
Bosutinib—BMPR2—digestive system—chronic kidney failure	0.00057	0.00213	CbGeAlD
Bosutinib—MAP2K2—renal system—chronic kidney failure	0.000569	0.00213	CbGeAlD
Bosutinib—CLK1—gonad—chronic kidney failure	0.000568	0.00212	CbGeAlD
Bosutinib—STK3—blood—chronic kidney failure	0.000567	0.00212	CbGeAlD
Bosutinib—EPHA4—urethra—chronic kidney failure	0.000566	0.00211	CbGeAlD
Bosutinib—EPHB3—digestive system—chronic kidney failure	0.000566	0.00211	CbGeAlD
Bosutinib—SIK1—kidney—chronic kidney failure	0.000563	0.0021	CbGeAlD
Bosutinib—MAP2K2—cardiovascular system—chronic kidney failure	0.000562	0.0021	CbGeAlD
Bosutinib—ROCK1—blood—chronic kidney failure	0.000559	0.00209	CbGeAlD
Bosutinib—MAP2K2—urethra—chronic kidney failure	0.000559	0.00209	CbGeAlD
Bosutinib—ULK3—urethra—chronic kidney failure	0.000559	0.00209	CbGeAlD
Bosutinib—SLK—nephron tubule—chronic kidney failure	0.000558	0.00208	CbGeAlD
Bosutinib—BMP2K—gonad—chronic kidney failure	0.000558	0.00208	CbGeAlD
Bosutinib—CSNK1E—cortex of kidney—chronic kidney failure	0.000557	0.00208	CbGeAlD
Bosutinib—EPHB4—nephron tubule—chronic kidney failure	0.000554	0.00207	CbGeAlD
Bosutinib—PTK2—renal system—chronic kidney failure	0.000553	0.00207	CbGeAlD
Bosutinib—TBK1—renal system—chronic kidney failure	0.000553	0.00207	CbGeAlD
Bosutinib—LRRK2—gonad—chronic kidney failure	0.000553	0.00206	CbGeAlD
Bosutinib—ERBB3—kidney—chronic kidney failure	0.000551	0.00206	CbGeAlD
Bosutinib—MAP2K2—kidney—chronic kidney failure	0.00055	0.00205	CbGeAlD
Bosutinib—MAP3K7—urethra—chronic kidney failure	0.00055	0.00205	CbGeAlD
Bosutinib—MAP4K4—digestive system—chronic kidney failure	0.000549	0.00205	CbGeAlD
Bosutinib—SIK1—cortex of kidney—chronic kidney failure	0.000548	0.00205	CbGeAlD
Bosutinib—Gefitinib—ABCB1—chronic kidney failure	0.000547	0.0741	CrCbGaD
Bosutinib—PTK2—cardiovascular system—chronic kidney failure	0.000547	0.00204	CbGeAlD
Bosutinib—TBK1—cardiovascular system—chronic kidney failure	0.000547	0.00204	CbGeAlD
Bosutinib—CYP3A4—urine—chronic kidney failure	0.000546	0.00204	CbGeAlD
Bosutinib—PTK2—urethra—chronic kidney failure	0.000544	0.00203	CbGeAlD
Bosutinib—TBK1—urethra—chronic kidney failure	0.000544	0.00203	CbGeAlD
Bosutinib—EPHA2—nephron tubule—chronic kidney failure	0.000543	0.00203	CbGeAlD
Bosutinib—FYN—nephron tubule—chronic kidney failure	0.000543	0.00203	CbGeAlD
Bosutinib—STK36—blood—chronic kidney failure	0.000539	0.00201	CbGeAlD
Bosutinib—PTK2B—gonad—chronic kidney failure	0.000539	0.00201	CbGeAlD
Bosutinib—ULK3—cortex of kidney—chronic kidney failure	0.000536	0.002	CbGeAlD
Bosutinib—MAP2K2—cortex of kidney—chronic kidney failure	0.000536	0.002	CbGeAlD
Bosutinib—PTK2—kidney—chronic kidney failure	0.000535	0.002	CbGeAlD
Bosutinib—TBK1—kidney—chronic kidney failure	0.000535	0.002	CbGeAlD
Bosutinib—MERTK—blood—chronic kidney failure	0.000533	0.00199	CbGeAlD
Bosutinib—RPS6KB1—renal system—chronic kidney failure	0.000532	0.00199	CbGeAlD
Bosutinib—MAP2K1—digestive system—chronic kidney failure	0.00053	0.00198	CbGeAlD
Bosutinib—MAP3K3—nephron tubule—chronic kidney failure	0.00053	0.00198	CbGeAlD
Bosutinib—MAP3K7—cortex of kidney—chronic kidney failure	0.000527	0.00197	CbGeAlD
Bosutinib—CSK—digestive system—chronic kidney failure	0.000527	0.00197	CbGeAlD
Bosutinib—RPS6KB1—cardiovascular system—chronic kidney failure	0.000526	0.00196	CbGeAlD
Bosutinib—CSNK1A1—digestive system—chronic kidney failure	0.000523	0.00195	CbGeAlD
Bosutinib—MAP4K4—blood—chronic kidney failure	0.000523	0.00195	CbGeAlD
Bosutinib—RPS6KB1—urethra—chronic kidney failure	0.000523	0.00195	CbGeAlD
Bosutinib—FGR—cardiovascular system—chronic kidney failure	0.000523	0.00195	CbGeAlD
Bosutinib—SIK1—gonad—chronic kidney failure	0.000522	0.00195	CbGeAlD
Bosutinib—PTK2—cortex of kidney—chronic kidney failure	0.000521	0.00195	CbGeAlD
Bosutinib—TBK1—cortex of kidney—chronic kidney failure	0.000521	0.00195	CbGeAlD
Bosutinib—AXL—cardiovascular system—chronic kidney failure	0.000521	0.00194	CbGeAlD
Bosutinib—HCK—digestive system—chronic kidney failure	0.00052	0.00194	CbGeAlD
Bosutinib—CLK1—digestive system—chronic kidney failure	0.00052	0.00194	CbGeAlD
Bosutinib—LCK—urethra—chronic kidney failure	0.00052	0.00194	CbGeAlD
Bosutinib—FGR—urethra—chronic kidney failure	0.00052	0.00194	CbGeAlD
Bosutinib—BCR—blood—chronic kidney failure	0.000519	0.00194	CbGeAlD
Bosutinib—NUAK2—blood—chronic kidney failure	0.000519	0.00194	CbGeAlD
Bosutinib—AXL—urethra—chronic kidney failure	0.000518	0.00193	CbGeAlD
Bosutinib—EPHA4—gonad—chronic kidney failure	0.000517	0.00193	CbGeAlD
Bosutinib—MAP3K12—blood—chronic kidney failure	0.000516	0.00193	CbGeAlD
Bosutinib—RPS6KB1—kidney—chronic kidney failure	0.000515	0.00192	CbGeAlD
Bosutinib—IRAK1—cortex of kidney—chronic kidney failure	0.000511	0.00191	CbGeAlD
Bosutinib—CAMK2G—digestive system—chronic kidney failure	0.00051	0.00191	CbGeAlD
Bosutinib—MAP2K2—gonad—chronic kidney failure	0.00051	0.00191	CbGeAlD
Bosutinib—ULK3—gonad—chronic kidney failure	0.00051	0.00191	CbGeAlD
Bosutinib—MAP3K2—gonad—chronic kidney failure	0.000507	0.00189	CbGeAlD
Bosutinib—MAP2K1—blood—chronic kidney failure	0.000505	0.00189	CbGeAlD
Bosutinib—EPHB4—renal system—chronic kidney failure	0.000504	0.00188	CbGeAlD
Bosutinib—CSK—blood—chronic kidney failure	0.000502	0.00187	CbGeAlD
Bosutinib—RPS6KB1—cortex of kidney—chronic kidney failure	0.000501	0.00187	CbGeAlD
Bosutinib—CSNK1A1—blood—chronic kidney failure	0.000498	0.00186	CbGeAlD
Bosutinib—SLK—urethra—chronic kidney failure	0.000498	0.00186	CbGeAlD
Bosutinib—EPHB4—cardiovascular system—chronic kidney failure	0.000498	0.00186	CbGeAlD
Bosutinib—PTK2—gonad—chronic kidney failure	0.000496	0.00185	CbGeAlD
Bosutinib—TBK1—gonad—chronic kidney failure	0.000496	0.00185	CbGeAlD
Bosutinib—AXL—cortex of kidney—chronic kidney failure	0.000496	0.00185	CbGeAlD
Bosutinib—HCK—blood—chronic kidney failure	0.000495	0.00185	CbGeAlD
Bosutinib—CLK1—blood—chronic kidney failure	0.000495	0.00185	CbGeAlD
Bosutinib—EPHB4—urethra—chronic kidney failure	0.000495	0.00185	CbGeAlD
Bosutinib—FYN—renal system—chronic kidney failure	0.000493	0.00184	CbGeAlD
Bosutinib—PTK2B—digestive system—chronic kidney failure	0.000493	0.00184	CbGeAlD
Bosutinib—ABL2—blood—chronic kidney failure	0.000492	0.00184	CbGeAlD
Bosutinib—YES1—nephron tubule—chronic kidney failure	0.00049	0.00183	CbGeAlD
Bosutinib—EPHA2—cardiovascular system—chronic kidney failure	0.000488	0.00182	CbGeAlD
Bosutinib—FYN—cardiovascular system—chronic kidney failure	0.000487	0.00182	CbGeAlD
Bosutinib—EPHB4—kidney—chronic kidney failure	0.000487	0.00182	CbGeAlD
Bosutinib—CAMK2G—blood—chronic kidney failure	0.000486	0.00182	CbGeAlD
Bosutinib—BMP2K—blood—chronic kidney failure	0.000486	0.00182	CbGeAlD
Bosutinib—EPHA2—urethra—chronic kidney failure	0.000485	0.00181	CbGeAlD
Bosutinib—CSNK1E—digestive system—chronic kidney failure	0.000485	0.00181	CbGeAlD
Bosutinib—FYN—urethra—chronic kidney failure	0.000484	0.00181	CbGeAlD
Bosutinib—TAOK3—nephron tubule—chronic kidney failure	0.000483	0.0018	CbGeAlD
Bosutinib—LRRK2—blood—chronic kidney failure	0.000482	0.0018	CbGeAlD
Bosutinib—SLK—cortex of kidney—chronic kidney failure	0.000478	0.00178	CbGeAlD
Bosutinib—FYN—kidney—chronic kidney failure	0.000477	0.00178	CbGeAlD
Bosutinib—MAP3K3—cardiovascular system—chronic kidney failure	0.000476	0.00178	CbGeAlD
Bosutinib—EPHB4—cortex of kidney—chronic kidney failure	0.000474	0.00177	CbGeAlD
Bosutinib—MAP4K5—urethra—chronic kidney failure	0.000473	0.00177	CbGeAlD
Bosutinib—MAP3K3—urethra—chronic kidney failure	0.000473	0.00177	CbGeAlD
Bosutinib—AXL—gonad—chronic kidney failure	0.000473	0.00176	CbGeAlD
Bosutinib—PTK2B—blood—chronic kidney failure	0.00047	0.00175	CbGeAlD
Bosutinib—ERBB3—digestive system—chronic kidney failure	0.000468	0.00175	CbGeAlD
Bosutinib—ULK3—digestive system—chronic kidney failure	0.000467	0.00174	CbGeAlD
Bosutinib—MAP2K2—digestive system—chronic kidney failure	0.000467	0.00174	CbGeAlD
Bosutinib—FYN—cortex of kidney—chronic kidney failure	0.000464	0.00173	CbGeAlD
Bosutinib—CSNK1E—blood—chronic kidney failure	0.000462	0.00173	CbGeAlD
Bosutinib—SIK1—blood—chronic kidney failure	0.000455	0.0017	CbGeAlD
Bosutinib—IRAK4—blood—chronic kidney failure	0.000455	0.0017	CbGeAlD
Bosutinib—PTK2—digestive system—chronic kidney failure	0.000454	0.00169	CbGeAlD
Bosutinib—TBK1—digestive system—chronic kidney failure	0.000454	0.00169	CbGeAlD
Bosutinib—MAP4K5—cortex of kidney—chronic kidney failure	0.000454	0.00169	CbGeAlD
Bosutinib—MAP3K3—cortex of kidney—chronic kidney failure	0.000454	0.00169	CbGeAlD
Bosutinib—EPHA4—blood—chronic kidney failure	0.00045	0.00168	CbGeAlD
Bosutinib—YES1—renal system—chronic kidney failure	0.000445	0.00166	CbGeAlD
Bosutinib—MAP2K2—blood—chronic kidney failure	0.000445	0.00166	CbGeAlD
Bosutinib—ULK3—blood—chronic kidney failure	0.000445	0.00166	CbGeAlD
Bosutinib—MAP3K2—blood—chronic kidney failure	0.000441	0.00165	CbGeAlD
Bosutinib—STK10—renal system—chronic kidney failure	0.000441	0.00165	CbGeAlD
Bosutinib—TAOK3—renal system—chronic kidney failure	0.000439	0.00164	CbGeAlD
Bosutinib—MAP3K7—blood—chronic kidney failure	0.000437	0.00163	CbGeAlD
Bosutinib—YES1—urethra—chronic kidney failure	0.000437	0.00163	CbGeAlD
Bosutinib—RPS6KB1—digestive system—chronic kidney failure	0.000437	0.00163	CbGeAlD
Bosutinib—STK10—cardiovascular system—chronic kidney failure	0.000436	0.00163	CbGeAlD
Bosutinib—TAOK3—cardiovascular system—chronic kidney failure	0.000434	0.00162	CbGeAlD
Bosutinib—FGR—digestive system—chronic kidney failure	0.000434	0.00162	CbGeAlD
Bosutinib—TBK1—blood—chronic kidney failure	0.000432	0.00161	CbGeAlD
Bosutinib—PTK2—blood—chronic kidney failure	0.000432	0.00161	CbGeAlD
Bosutinib—MAP4K5—gonad—chronic kidney failure	0.000432	0.00161	CbGeAlD
Bosutinib—MAP3K3—gonad—chronic kidney failure	0.000432	0.00161	CbGeAlD
Bosutinib—TAOK3—urethra—chronic kidney failure	0.000432	0.00161	CbGeAlD
Bosutinib—YES1—kidney—chronic kidney failure	0.00043	0.00161	CbGeAlD
Bosutinib—SRC—renal system—chronic kidney failure	0.000428	0.0016	CbGeAlD
Bosutinib—STK10—kidney—chronic kidney failure	0.000426	0.00159	CbGeAlD
Bosutinib—TAOK3—kidney—chronic kidney failure	0.000425	0.00159	CbGeAlD
Bosutinib—IRAK1—blood—chronic kidney failure	0.000424	0.00158	CbGeAlD
Bosutinib—SRC—cardiovascular system—chronic kidney failure	0.000423	0.00158	CbGeAlD
Bosutinib—YES1—cortex of kidney—chronic kidney failure	0.000419	0.00156	CbGeAlD
Bosutinib—RPS6KB1—blood—chronic kidney failure	0.000416	0.00155	CbGeAlD
Bosutinib—SRC—kidney—chronic kidney failure	0.000414	0.00155	CbGeAlD
Bosutinib—TAOK3—cortex of kidney—chronic kidney failure	0.000414	0.00154	CbGeAlD
Bosutinib—FGR—blood—chronic kidney failure	0.000413	0.00154	CbGeAlD
Bosutinib—LCK—blood—chronic kidney failure	0.000413	0.00154	CbGeAlD
Bosutinib—EPHB4—digestive system—chronic kidney failure	0.000413	0.00154	CbGeAlD
Bosutinib—EPHA2—digestive system—chronic kidney failure	0.000405	0.00151	CbGeAlD
Bosutinib—FYN—digestive system—chronic kidney failure	0.000404	0.00151	CbGeAlD
Bosutinib—YES1—gonad—chronic kidney failure	0.000399	0.00149	CbGeAlD
Bosutinib—SLK—blood—chronic kidney failure	0.000396	0.00148	CbGeAlD
Bosutinib—STK10—gonad—chronic kidney failure	0.000396	0.00148	CbGeAlD
Bosutinib—EPHB4—blood—chronic kidney failure	0.000393	0.00147	CbGeAlD
Bosutinib—MAP2K5—cardiovascular system—chronic kidney failure	0.000389	0.00145	CbGeAlD
Bosutinib—MAP2K5—urethra—chronic kidney failure	0.000387	0.00144	CbGeAlD
Bosutinib—EPHA2—blood—chronic kidney failure	0.000386	0.00144	CbGeAlD
Bosutinib—FYN—blood—chronic kidney failure	0.000385	0.00144	CbGeAlD
Bosutinib—SRC—gonad—chronic kidney failure	0.000384	0.00143	CbGeAlD
Bosutinib—CSF1R—cardiovascular system—chronic kidney failure	0.00038	0.00142	CbGeAlD
Bosutinib—CSF1R—urethra—chronic kidney failure	0.000378	0.00141	CbGeAlD
Bosutinib—MAP4K5—blood—chronic kidney failure	0.000377	0.00141	CbGeAlD
Bosutinib—MAP3K3—blood—chronic kidney failure	0.000377	0.00141	CbGeAlD
Bosutinib—MAP2K5—cortex of kidney—chronic kidney failure	0.000371	0.00138	CbGeAlD
Bosutinib—YES1—digestive system—chronic kidney failure	0.000365	0.00136	CbGeAlD
Bosutinib—STK10—digestive system—chronic kidney failure	0.000362	0.00135	CbGeAlD
Bosutinib—TAOK3—digestive system—chronic kidney failure	0.00036	0.00135	CbGeAlD
Bosutinib—SRC—digestive system—chronic kidney failure	0.000351	0.00131	CbGeAlD
Bosutinib—YES1—blood—chronic kidney failure	0.000348	0.0013	CbGeAlD
Bosutinib—CSF1R—gonad—chronic kidney failure	0.000345	0.00129	CbGeAlD
Bosutinib—STK10—blood—chronic kidney failure	0.000345	0.00129	CbGeAlD
Bosutinib—TAOK3—blood—chronic kidney failure	0.000343	0.00128	CbGeAlD
Bosutinib—PDGFRB—renal system—chronic kidney failure	0.000341	0.00127	CbGeAlD
Bosutinib—PDGFRB—cardiovascular system—chronic kidney failure	0.000337	0.00126	CbGeAlD
Bosutinib—PDGFRB—urethra—chronic kidney failure	0.000335	0.00125	CbGeAlD
Bosutinib—SRC—blood—chronic kidney failure	0.000335	0.00125	CbGeAlD
Bosutinib—ABL1—nephron tubule—chronic kidney failure	0.000334	0.00125	CbGeAlD
Bosutinib—PDGFRB—kidney—chronic kidney failure	0.00033	0.00123	CbGeAlD
Bosutinib—PDGFRB—cortex of kidney—chronic kidney failure	0.000321	0.0012	CbGeAlD
Bosutinib—CSF1R—digestive system—chronic kidney failure	0.000315	0.00118	CbGeAlD
Bosutinib—MAP2K5—blood—chronic kidney failure	0.000308	0.00115	CbGeAlD
Bosutinib—PDGFRB—gonad—chronic kidney failure	0.000306	0.00114	CbGeAlD
Bosutinib—ABL1—renal system—chronic kidney failure	0.000304	0.00113	CbGeAlD
Bosutinib—CSF1R—blood—chronic kidney failure	0.0003	0.00112	CbGeAlD
Bosutinib—ABL1—cardiovascular system—chronic kidney failure	0.0003	0.00112	CbGeAlD
Bosutinib—ABL1—urethra—chronic kidney failure	0.000298	0.00111	CbGeAlD
Bosutinib—ABL1—kidney—chronic kidney failure	0.000294	0.0011	CbGeAlD
Bosutinib—ABL1—cortex of kidney—chronic kidney failure	0.000286	0.00107	CbGeAlD
Bosutinib—CYP3A4—blood plasma—chronic kidney failure	0.000285	0.00106	CbGeAlD
Bosutinib—PDGFRB—digestive system—chronic kidney failure	0.00028	0.00104	CbGeAlD
Bosutinib—ABL1—gonad—chronic kidney failure	0.000272	0.00102	CbGeAlD
Bosutinib—PDGFRB—blood—chronic kidney failure	0.000266	0.000995	CbGeAlD
Bosutinib—ABL1—digestive system—chronic kidney failure	0.000249	0.000931	CbGeAlD
Bosutinib—ABL1—blood—chronic kidney failure	0.000237	0.000887	CbGeAlD
Bosutinib—ABCB1—blood plasma—chronic kidney failure	0.000202	0.000753	CbGeAlD
Bosutinib—CYP3A4—renal system—chronic kidney failure	0.000133	0.000498	CbGeAlD
Bosutinib—CYP3A4—kidney—chronic kidney failure	0.000129	0.000482	CbGeAlD
Bosutinib—CYP3A4—digestive system—chronic kidney failure	0.000109	0.000409	CbGeAlD
Bosutinib—CYP3A4—blood—chronic kidney failure	0.000104	0.00039	CbGeAlD
Bosutinib—ABCB1—nephron tubule—chronic kidney failure	0.000104	0.000388	CbGeAlD
Bosutinib—ABCB1—renal system—chronic kidney failure	9.45e-05	0.000353	CbGeAlD
Bosutinib—ABCB1—cardiovascular system—chronic kidney failure	9.34e-05	0.000349	CbGeAlD
Bosutinib—ABCB1—urethra—chronic kidney failure	9.28e-05	0.000347	CbGeAlD
Bosutinib—ABCB1—kidney—chronic kidney failure	9.13e-05	0.000341	CbGeAlD
Bosutinib—ABCB1—cortex of kidney—chronic kidney failure	8.9e-05	0.000332	CbGeAlD
Bosutinib—ABCB1—gonad—chronic kidney failure	8.47e-05	0.000316	CbGeAlD
Bosutinib—ABCB1—digestive system—chronic kidney failure	7.75e-05	0.000289	CbGeAlD
Bosutinib—ABCB1—blood—chronic kidney failure	7.38e-05	0.000276	CbGeAlD
Bosutinib—PDGFRB—Signaling Pathways—POMC—chronic kidney failure	3.32e-06	8.27e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—NOS3—chronic kidney failure	3.32e-06	8.27e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—HMGCR—chronic kidney failure	3.32e-06	8.26e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IRS1—chronic kidney failure	3.31e-06	8.24e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—LPL—chronic kidney failure	3.28e-06	8.16e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IGF1—chronic kidney failure	3.27e-06	8.16e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PRKD1—chronic kidney failure	3.26e-06	8.12e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PRKAG2—chronic kidney failure	3.26e-06	8.12e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CYP2B6—chronic kidney failure	3.26e-06	8.12e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—POMC—chronic kidney failure	3.25e-06	8.1e-06	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—ALB—chronic kidney failure	3.25e-06	8.1e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—TGFB1—chronic kidney failure	3.25e-06	8.1e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CCL2—chronic kidney failure	3.25e-06	8.1e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—FASN—chronic kidney failure	3.24e-06	8.08e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—VEGFA—chronic kidney failure	3.24e-06	8.07e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—VEGFA—chronic kidney failure	3.24e-06	8.07e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—KRAS—chronic kidney failure	3.22e-06	8.02e-06	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—KRAS—chronic kidney failure	3.21e-06	8.01e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—TGFB1—chronic kidney failure	3.2e-06	7.98e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—POMC—chronic kidney failure	3.2e-06	7.98e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—RELA—chronic kidney failure	3.2e-06	7.96e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IGF1—chronic kidney failure	3.2e-06	7.96e-06	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—IL6—chronic kidney failure	3.19e-06	7.95e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—POMC—chronic kidney failure	3.19e-06	7.93e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CCL2—chronic kidney failure	3.18e-06	7.93e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL1B—chronic kidney failure	3.18e-06	7.91e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—PTGS2—chronic kidney failure	3.15e-06	7.85e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CCL2—chronic kidney failure	3.13e-06	7.8e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IGF1—chronic kidney failure	3.13e-06	7.79e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—VEGFA—chronic kidney failure	3.12e-06	7.78e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CCL2—chronic kidney failure	3.12e-06	7.76e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—SERPINE1—chronic kidney failure	3.11e-06	7.75e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NGF—chronic kidney failure	3.1e-06	7.73e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—TGFB1—chronic kidney failure	3.09e-06	7.69e-06	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—IL6—chronic kidney failure	3.08e-06	7.68e-06	CbGpPWpGaD
Bosutinib—ERBB3—Disease—IL6—chronic kidney failure	3.08e-06	7.68e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IGF1—chronic kidney failure	3.08e-06	7.67e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—SERPINE1—chronic kidney failure	3.08e-06	7.67e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—KRAS—chronic kidney failure	3.08e-06	7.67e-06	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—IL6—chronic kidney failure	3.08e-06	7.66e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IGF1—chronic kidney failure	3.06e-06	7.63e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—NFKB1—chronic kidney failure	3.06e-06	7.63e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL1B—chronic kidney failure	3.06e-06	7.62e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—SREBF2—chronic kidney failure	3.05e-06	7.6e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—F2—chronic kidney failure	3.04e-06	7.56e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—PTGS2—chronic kidney failure	3.04e-06	7.56e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—SERPINE1—chronic kidney failure	3.03e-06	7.56e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CCR5—chronic kidney failure	3.02e-06	7.52e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—NFKB1—chronic kidney failure	3.02e-06	7.52e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—KRAS—chronic kidney failure	3.01e-06	7.5e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CYP3A4—chronic kidney failure	3.01e-06	7.49e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—RELA—chronic kidney failure	3e-06	7.46e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—TGFB1—chronic kidney failure	2.97e-06	7.4e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—TGFB1—chronic kidney failure	2.97e-06	7.4e-06	CbGpPWpGaD
Bosutinib—PTK2—Immune System—IL6—chronic kidney failure	2.97e-06	7.4e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—SERPINE1—chronic kidney failure	2.97e-06	7.4e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—NOS3—chronic kidney failure	2.97e-06	7.39e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—KRAS—chronic kidney failure	2.97e-06	7.39e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—NFKB1—chronic kidney failure	2.96e-06	7.38e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—ABCA1—chronic kidney failure	2.96e-06	7.36e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GCKR—chronic kidney failure	2.95e-06	7.34e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ABCC3—chronic kidney failure	2.95e-06	7.34e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—NOS3—chronic kidney failure	2.94e-06	7.32e-06	CbGpPWpGaD
Bosutinib—YES1—Immune System—IL6—chronic kidney failure	2.93e-06	7.3e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—F2—chronic kidney failure	2.93e-06	7.29e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—SERPINE1—chronic kidney failure	2.93e-06	7.29e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—SERPINE1—chronic kidney failure	2.91e-06	7.25e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—NOS3—chronic kidney failure	2.9e-06	7.22e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—LPIN1—chronic kidney failure	2.88e-06	7.18e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—KRAS—chronic kidney failure	2.88e-06	7.17e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IRS1—chronic kidney failure	2.87e-06	7.16e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—TGFB1—chronic kidney failure	2.87e-06	7.14e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—NFKB1—chronic kidney failure	2.86e-06	7.13e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—KRAS—chronic kidney failure	2.86e-06	7.12e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—NFKB1—chronic kidney failure	2.85e-06	7.11e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—NOS3—chronic kidney failure	2.84e-06	7.07e-06	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—IL6—chronic kidney failure	2.83e-06	7.06e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—LRP2—chronic kidney failure	2.83e-06	7.04e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CYP2C18—chronic kidney failure	2.83e-06	7.04e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—KRAS—chronic kidney failure	2.81e-06	7.01e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—TGFB1—chronic kidney failure	2.8e-06	6.98e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—RELA—chronic kidney failure	2.79e-06	6.96e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—NOS3—chronic kidney failure	2.79e-06	6.96e-06	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—IL6—chronic kidney failure	2.78e-06	6.93e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—VEGFA—chronic kidney failure	2.78e-06	6.92e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—NOS3—chronic kidney failure	2.78e-06	6.92e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IRS1—chronic kidney failure	2.77e-06	6.9e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—POMC—chronic kidney failure	2.77e-06	6.89e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—KRAS—chronic kidney failure	2.75e-06	6.86e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—KRAS—chronic kidney failure	2.75e-06	6.86e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—KRAS—chronic kidney failure	2.74e-06	6.84e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—VEGFA—chronic kidney failure	2.74e-06	6.83e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—TGFB1—chronic kidney failure	2.74e-06	6.81e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—RELA—chronic kidney failure	2.73e-06	6.79e-06	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—IL6—chronic kidney failure	2.72e-06	6.78e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL1B—chronic kidney failure	2.71e-06	6.75e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CCL2—chronic kidney failure	2.71e-06	6.74e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—NFKB1—chronic kidney failure	2.7e-06	6.72e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—PTGS2—chronic kidney failure	2.69e-06	6.7e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—KRAS—chronic kidney failure	2.69e-06	6.69e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—KRAS—chronic kidney failure	2.67e-06	6.66e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—RELA—chronic kidney failure	2.67e-06	6.65e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—POMC—chronic kidney failure	2.67e-06	6.64e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IGF1—chronic kidney failure	2.66e-06	6.63e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—KRAS—chronic kidney failure	2.65e-06	6.61e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—KRAS—chronic kidney failure	2.65e-06	6.59e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—TGFB1—chronic kidney failure	2.64e-06	6.57e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—KRAS—chronic kidney failure	2.63e-06	6.55e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—RELA—chronic kidney failure	2.63e-06	6.55e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—TGFB1—chronic kidney failure	2.62e-06	6.53e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—IL6—chronic kidney failure	2.62e-06	6.52e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—RELA—chronic kidney failure	2.61e-06	6.51e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CCL2—chronic kidney failure	2.61e-06	6.5e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—VEGFA—chronic kidney failure	2.6e-06	6.47e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—KRAS—chronic kidney failure	2.6e-06	6.47e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—F2—chronic kidney failure	2.59e-06	6.45e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IGF1—chronic kidney failure	2.56e-06	6.39e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—TGFB1—chronic kidney failure	2.55e-06	6.35e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—KRAS—chronic kidney failure	2.53e-06	6.31e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—NFKB1—chronic kidney failure	2.53e-06	6.29e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—SERPINE1—chronic kidney failure	2.53e-06	6.29e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—TGFB1—chronic kidney failure	2.52e-06	6.27e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—IL6—chronic kidney failure	2.5e-06	6.24e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CAT—chronic kidney failure	2.5e-06	6.23e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—KRAS—chronic kidney failure	2.5e-06	6.23e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IRS1—chronic kidney failure	2.45e-06	6.1e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—IL6—chronic kidney failure	2.45e-06	6.1e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—VEGFA—chronic kidney failure	2.45e-06	6.1e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—KRAS—chronic kidney failure	2.44e-06	6.08e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—SERPINE1—chronic kidney failure	2.44e-06	6.07e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—KRAS—chronic kidney failure	2.43e-06	6.05e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—IL6—chronic kidney failure	2.41e-06	6.01e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—NOS3—chronic kidney failure	2.41e-06	6.01e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CPT1A—chronic kidney failure	2.4e-06	5.98e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—TGFB1—chronic kidney failure	2.39e-06	5.94e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—KRAS—chronic kidney failure	2.36e-06	5.88e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—POMC—chronic kidney failure	2.36e-06	5.88e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—NFKB1—chronic kidney failure	2.36e-06	5.87e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—IL6—chronic kidney failure	2.34e-06	5.84e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—LIPC—chronic kidney failure	2.34e-06	5.83e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CYP2C19—chronic kidney failure	2.34e-06	5.83e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—KRAS—chronic kidney failure	2.33e-06	5.8e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—IL6—chronic kidney failure	2.33e-06	5.79e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—NOS3—chronic kidney failure	2.33e-06	5.79e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—LPL—chronic kidney failure	2.32e-06	5.78e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CCL2—chronic kidney failure	2.31e-06	5.75e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—NFKB1—chronic kidney failure	2.3e-06	5.73e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—IL6—chronic kidney failure	2.29e-06	5.7e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—KRAS—chronic kidney failure	2.29e-06	5.69e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—TGFB1—chronic kidney failure	2.28e-06	5.67e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—RELA—chronic kidney failure	2.27e-06	5.66e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IGF1—chronic kidney failure	2.27e-06	5.65e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—NFKB1—chronic kidney failure	2.25e-06	5.61e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TGFB1—chronic kidney failure	2.25e-06	5.6e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—IL6—chronic kidney failure	2.24e-06	5.58e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—IL6—chronic kidney failure	2.24e-06	5.58e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CYP1A1—chronic kidney failure	2.24e-06	5.58e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—IL6—chronic kidney failure	2.23e-06	5.56e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—NFKB1—chronic kidney failure	2.22e-06	5.52e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—KRAS—chronic kidney failure	2.21e-06	5.5e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—NFKB1—chronic kidney failure	2.2e-06	5.49e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—KRAS—chronic kidney failure	2.2e-06	5.49e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—TGFB1—chronic kidney failure	2.2e-06	5.47e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—RELA—chronic kidney failure	2.19e-06	5.45e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—IL6—chronic kidney failure	2.19e-06	5.44e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—IL6—chronic kidney failure	2.18e-06	5.42e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—SCARB1—chronic kidney failure	2.16e-06	5.39e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—IL6—chronic kidney failure	2.16e-06	5.38e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—SERPINE1—chronic kidney failure	2.16e-06	5.37e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—IL6—chronic kidney failure	2.15e-06	5.36e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PTGS1—chronic kidney failure	2.14e-06	5.33e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IL6—chronic kidney failure	2.14e-06	5.33e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—VEGFA—chronic kidney failure	2.14e-06	5.33e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—IL6—chronic kidney failure	2.11e-06	5.26e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—KRAS—chronic kidney failure	2.11e-06	5.26e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—SREBF1—chronic kidney failure	2.1e-06	5.23e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—MTHFR—chronic kidney failure	2.09e-06	5.2e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—VEGFA—chronic kidney failure	2.09e-06	5.2e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—KRAS—chronic kidney failure	2.08e-06	5.18e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—IL6—chronic kidney failure	2.06e-06	5.13e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NOS3—chronic kidney failure	2.06e-06	5.13e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PPARA—chronic kidney failure	2.05e-06	5.1e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—VEGFA—chronic kidney failure	2.04e-06	5.09e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—HMGCR—chronic kidney failure	2.04e-06	5.09e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—IL6—chronic kidney failure	2.04e-06	5.07e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—KRAS—chronic kidney failure	2.03e-06	5.06e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—VEGFA—chronic kidney failure	2.01e-06	5.01e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—VEGFA—chronic kidney failure	2e-06	4.98e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—FASN—chronic kidney failure	2e-06	4.98e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—IL6—chronic kidney failure	1.99e-06	4.95e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—IL6—chronic kidney failure	1.98e-06	4.92e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TGFB1—chronic kidney failure	1.96e-06	4.89e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—KRAS—chronic kidney failure	1.95e-06	4.86e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—TGFB1—chronic kidney failure	1.94e-06	4.84e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—RELA—chronic kidney failure	1.94e-06	4.83e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—IL6—chronic kidney failure	1.92e-06	4.79e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TGFB1—chronic kidney failure	1.92e-06	4.77e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—NFKB1—chronic kidney failure	1.92e-06	4.77e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—IL6—chronic kidney failure	1.9e-06	4.72e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TGFB1—chronic kidney failure	1.88e-06	4.67e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL6—chronic kidney failure	1.86e-06	4.63e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TGFB1—chronic kidney failure	1.85e-06	4.6e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—NFKB1—chronic kidney failure	1.85e-06	4.6e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TGFB1—chronic kidney failure	1.84e-06	4.57e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ABCA1—chronic kidney failure	1.82e-06	4.54e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—KRAS—chronic kidney failure	1.82e-06	4.53e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—KRAS—chronic kidney failure	1.8e-06	4.48e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—IL6—chronic kidney failure	1.8e-06	4.48e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL6—chronic kidney failure	1.79e-06	4.46e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—KRAS—chronic kidney failure	1.77e-06	4.42e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—VEGFA—chronic kidney failure	1.74e-06	4.33e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—KRAS—chronic kidney failure	1.74e-06	4.33e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—IL6—chronic kidney failure	1.72e-06	4.28e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—KRAS—chronic kidney failure	1.71e-06	4.26e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—KRAS—chronic kidney failure	1.7e-06	4.24e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—IL6—chronic kidney failure	1.69e-06	4.22e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—VEGFA—chronic kidney failure	1.68e-06	4.17e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—POMC—chronic kidney failure	1.67e-06	4.16e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—IL6—chronic kidney failure	1.65e-06	4.12e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NFKB1—chronic kidney failure	1.63e-06	4.07e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TGFB1—chronic kidney failure	1.6e-06	3.97e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL6—chronic kidney failure	1.59e-06	3.95e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CAT—chronic kidney failure	1.54e-06	3.84e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TGFB1—chronic kidney failure	1.54e-06	3.83e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—ALB—chronic kidney failure	1.52e-06	3.79e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ABCB1—chronic kidney failure	1.5e-06	3.73e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—VEGFA—chronic kidney failure	1.48e-06	3.69e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IL6—chronic kidney failure	1.48e-06	3.68e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—KRAS—chronic kidney failure	1.48e-06	3.68e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—IL6—chronic kidney failure	1.46e-06	3.65e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—NOS3—chronic kidney failure	1.46e-06	3.63e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IL6—chronic kidney failure	1.44e-06	3.6e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—LPL—chronic kidney failure	1.43e-06	3.56e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—KRAS—chronic kidney failure	1.42e-06	3.55e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IL6—chronic kidney failure	1.41e-06	3.52e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IL6—chronic kidney failure	1.39e-06	3.47e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IL6—chronic kidney failure	1.38e-06	3.45e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CYP1A1—chronic kidney failure	1.38e-06	3.44e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TGFB1—chronic kidney failure	1.36e-06	3.39e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PTGS2—chronic kidney failure	1.33e-06	3.32e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—MTHFR—chronic kidney failure	1.29e-06	3.2e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PPARA—chronic kidney failure	1.26e-06	3.14e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—KRAS—chronic kidney failure	1.26e-06	3.14e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL6—chronic kidney failure	1.2e-06	2.99e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL6—chronic kidney failure	1.16e-06	2.89e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—POMC—chronic kidney failure	1.03e-06	2.56e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL6—chronic kidney failure	1.03e-06	2.55e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ALB—chronic kidney failure	9.38e-07	2.34e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—NOS3—chronic kidney failure	8.97e-07	2.23e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PTGS2—chronic kidney failure	8.21e-07	2.04e-06	CbGpPWpGaD
